BREAKING
Importance
60
Trust
71
Urgency
95
Rhythm Pharmaceuticals Gains on European Approval for Obesity Drug By Investing.com - Investing.com India
Analysis
Rhythm got the green light in Europe to sell its obesity drug. This adds another player to the crowded weight-loss market in the EU.
- Rhythm Pharmaceuticals received European approval for an obesity drug
- Company shares rose on the news
Obesity Drug FDA News1mo
Read